151 filings
8-K
OCX
Oncocyte Corporation
12 Apr 24
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
6:04am
8-K
OCX
Oncocyte Corporation
11 Apr 24
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
5:28pm
8-K
OCX
Oncocyte Corporation
23 Jan 24
Regulation FD Disclosure
4:39pm
8-K
OCX
Oncocyte Corporation
9 Nov 23
Oncocyte Reports Third Quarter 2023 Financial Results
7:05am
8-K/A
OCX
Oncocyte Corporation
10 Oct 23
Changes in Registrant's Certifying Accountant
4:48pm
8-K
hu68s8newucg8v
5 Oct 23
Changes in Registrant's Certifying Accountant
4:05pm
8-K
elsgk4z b0z0hc8iw
20 Sep 23
Entry into a Material Definitive Agreement
9:00am
8-K
6wq7x357xgxb494daoss
28 Aug 23
Other Events
4:05pm
8-K
wueijmds1h 3hwz
10 Aug 23
Oncocyte Reports Second Quarter 2023 Financial Results
7:05am
8-K
rfrtmq0r
24 Jul 23
ONCOCYTE ANNOUNCES 1-for-20 reverse stock split
5:28pm
8-K
rdn8x9 ev5r
14 Jul 23
Departure of Directors or Certain Officers
6:03am
8-K
j1pwsd2441h
29 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
7m6f5ci
8 Jun 23
Departure of Directors or Certain Officers
6:29pm
8-K
uhnj v7tvaqo
6 Jun 23
Regulation FD Disclosure
5:12pm
8-K
egkw458
11 May 23
Oncocyte Reports First Quarter 2023 Financial Results
8:05am
8-K
awt 81wyx
13 Apr 23
Oncocyte Announces Reduction in Force
4:50pm
8-K
5mqa7za
6 Apr 23
Entry into a Material Definitive Agreement
5:25pm
8-K
vo1w5l7
5 Apr 23
Results of Operations and Financial Condition
9:00am
8-K
3edw9 m1yfw46pw9y
31 Mar 23
ONCOCYTE REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS and PLANS TO FILE FORM 12b-25 to extend filing date of its form 10-k
5:28pm
8-K
38eyctwkjsjwurqp1h
2 Mar 23
Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer
9:05am